SA study shows J&J vaccine protects against death, co-lead investigator says

A South African study has shown the Johnson & Johnson Covid-19 vaccine offers over 90% protection against death, the joint lead investigator for the country’s J&J trial, Glenda Gray, said on Friday.

“We can report that the single jab J&J vaccine protected between 91% to 96.2% of healthcare workers against death,” Gray said.

“This was our primary endpoint and we are able to say this vaccine protected health workers against death.”